Molecular Diagnostics Quarterly Datastream, 2025

    Published: April 2, 2025 | Price: $7,700.00 – $11,000.00

    Important Note: The Kalorama Molecular Diagnostics Quarterly Datastream is exclusively available to purchasers of our annual reports: Worldwide In Vitro Diagnostic (IVD) Tests, World Market for Molecular Diagnostics, or Molecular Point-of-Care (mPOC). This quarterly update covers markets detailed in these reports. Stay Ahead with the Latest Information: Subscribers will receive data updates after each financial quarter for one year, totaling four updates (Q4 2024, Q1 2025, Q2 2025, Q3 2025). These updates are provided in an Excel spreadsheet, making them easily...
    The World Market for Cancer Diagnostics, 2024-2029

    Published: January 13, 2025 | Price: $5,000.00 – $10,500.00

    The landscape of cancer diagnostics is evolving with molecular and protein biomarkers indispensable for accurate diagnosis, therapy selection, monitoring treatment response, and early detection of cancer recurrence. Kalorama Information’s The World Market for Cancer Diagnostics, 2024-2029 delivers an authoritative and comprehensive analysis of the global cancer in vitro diagnostics (IVD) market, including industry-defining trends, market sizing, and growth opportunities. This report offers an in-depth review of the cancer IVD market, including expert insights into significant segment markets: Oncology molecular assays...
    The Worldwide Market for Mass Spectrometry in Clinical Labs, 2024

    Published: September 11, 2024 | Price: $5,000.00 – $10,500.00

    Mass spectrometry (MS) is increasingly being integrated into clinical laboratories, revolutionizing diagnostics with its advanced sensitivity and specificity. This technology, once primarily utilized in research settings, is now making significant strides in clinical applications, particularly in areas like therapeutic drug monitoring, metabolite testing, steroid hormone analysis, and vitamin D testing. The growing demand for MS in clinical settings is driven by its ability to outperform traditional immunoassays in terms of accuracy and precision. Kalorama Information’s The Worldwide Market for Mass...
    The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028

    Published: July 26, 2024 | Price: $5,000.00 – $10,500.00

    Kalorama Information’s latest report, The Worldwide Market for Laboratory-Developed Tests (LDTs), 2023-2028, is now available for purchase. This comprehensive study delves into the dynamic landscape of LDTs, exploring both the services market and the market for test products sold to clinical laboratories. The Worldwide Market for Laboratory-Developed Tests includes comprehensive analysis of the effects of the FDA's new "Medical Devices: Laboratory Developed Tests" rule, passed in April 2024, which subjects LDTs to significantly greater regulatory oversight. Inclusion Criteria for LDTs: 2023-2024: LDTs...
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029

    Published: April 30, 2024 | Price: $5,000.00 – $10,500.00

    Authoritative market research on cell therapy, gene therapy, and RNA therapy analyzing markets by disease type Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body's immune system.  Recent years have seen an increase in new therapies and the pipeline indicates this trend will continue.  A large range of therapeutic areas from oncology to cardiology have seen rapidly proliferating clinical trials. Cell...
    Molecular Diagnostics Quarterly Datastream, 2024

    Published: November 30, 2024 | Price: $10,500.00

    NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests report, World Market for Molecular Diagnostics report or Molecular Point-of-Care (mPOC) report.  All in any edition.  This is because this is a quarterly update to markets covered in these reports.   The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel spreadsheet...
    Molecular Diagnostics in Oncology, Genetic/Inherited Diseases, and NIPT, 2023-2028

    Published: November 29, 2023 | Price: $5,000.00 – $10,000.00

    In recent decades, the introduction of various new genetic technologies for research use and diagnostics has revolutionized many areas and opened new frontiers in healthcare.  For example, next-generation sequencing (NGS) technologies have become widely used in genetic diseases, and have grown rapidly in oncology, due to the comprehensive insights they can provide at a relatively low cost.  While older, PCR continues to be innovated and remains a central tool in molecular diagnostics laboratories of all kinds, and in situ hybridization...
    Molecular Diagnostics Quarterly Datastream

    Published: May 5, 2022 | Price: $10,000.00

    NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests Report, World Molecular Diagnostics Report or Molecular Point-of-Care (POC) report.  All in any edition.  This is because this is a quarterly update to markets covered in these reports.     The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel...
    Cell Therapy and Gene Therapy Markets, 2021-2031

    Published: February 18, 2022 | Price: $6,000.00 – $12,000.00

    Authoritative Information on Cell and Gene Therapy Markets Cell Therapy And Gene Therapy Markets, 2021-2031 from Kalorama Information presents the market in segments that provide an overview of disease epidemiology, market estimates and forecasts, and competitive summary of leading providers: Cell and Gene Therapy Market Summary by Product Segment, 2021-2031 ($ millions) (Dermatological, Cardiovascular – Blood, Oncology, Ophthalmic, Musculoskeletal, Other conditions, Total Market) Cell and Gene Therapy Market Summary by Method, 2021-2031 ($ millions) (Cell Therapy, Gene Therapy, Total Market) Cell...
    World Market for Cancer Diagnostics

    Published: November 22, 2021 | Price: $9,000.00 – $12,000.00

    Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence.  The World Market for Cancer Diagnostics, as well as relevant industry merger data provided by Kalorama Information, provides authoritative and complete analysis of the cancer testing industry, with expert market sizing and opportunity assessment. Segment markets for cancer testing are comprehensively covered in Kalorama Information’s World Market for Cancer Diagnostics. ...
    Cell and Gene Therapy Business Outlook

    Published: January 1, 2022 | Price:

    How Do You Plan to Keep Up With Developments in The Business of Cell and Gene Therapy in 2022? Consider Cell and Gene Therapy Business Outlook Each week brings news in Cell and Gene Therapy, from advances in clinical trials to product launches, from tools development to mergers and acquisitions.  It can be a daunting task to keep up.  Yet these developments are too fast-moving and significant for healthcare companies of any type to ignore.  Now from Science and Medicine...
    Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities

    Published: June 17, 2020 | Price: $6,000.00 – $12,000.00

    Kalorama Information's report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment.  Especially in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes.   Companion diagnostics can also decrease costs by identifying the patient population that will most likely benefit...
    Cell Therapy and Gene Therapy Markets

    Published: April 27, 2020 | Price: $5,500.00 – $11,000.00

    What is the Size of the Cell and Gene Therapy Market? According to the latest report on the cell and gene therapy market from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3,866 million And most of the market is for the treatment of cancer. Dermatological, Cardiovascular – Blood, Oncology, Ophthalmic, Musculoskeletal and other conditions. With the COVID-19 crisis, there are some efforts to adapt this promising technology to the treatment and...